Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Inorg Biochem ; 145: 11-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25594947

ABSTRACT

A range of bidentate N,O-donor ligands of the imidazolyl-carboxylate moiety, which partially mimic naturally occurring bioligands, were prepared and reacted with the oxidovanadium(IV) ion to form the corresponding bis-coordinated oxidovanadium(IV) complexes. The aqueous pH-metric chemical speciation was investigated using glass electrode potentiometry, which allowed for the determination of protonation and stability constants of the ligands and complexes, respectively. The species distribution diagrams generated from this information gave evidence that the bis[(imidazolyl)carboxylato]oxovanadium(IV) complexes possess a broad pH-metric stability. The complexes improved glucose uptake in cell cultures using 3T3-L1 adipocytes, C2C12 muscle cells and Chang liver cells. The PTP inhibition studies indicated that the mechanism underlying insulin-stimulated glucose uptake was possibly via the protein tyrosine phosphorylation through the inhibition of the protein tyrosine phosphatase 1B (PTP 1B). The vanadium compounds also demonstrated the inhibition of D-dimer formation, suggesting that these compounds could potentially relieve a hypercoagulative state in diabetic patients.


Subject(s)
Coordination Complexes/pharmacology , Hydrogen-Ion Concentration , Hypoglycemic Agents/pharmacology , 3T3-L1 Cells , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Anticoagulants/pharmacology , Coordination Complexes/chemistry , Crystallography, X-Ray , Enzyme Inhibitors/pharmacology , Glucose/metabolism , Hypoglycemic Agents/chemistry , In Vitro Techniques , Mice , Models, Chemical
2.
J Ethnopharmacol ; 138(1): 67-75, 2011 Oct 31.
Article in English | MEDLINE | ID: mdl-21893184

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Leonotis leonurus L. (Lamiaceae) is used as a traditional medicine for a variety of ailments in South Africa. The diterpene marrubiin is the major product constituent in specimens of this plant occurring in South Africa. MATERIALS AND METHODS: Marrubiin isolated from South African specimens of L. leonurus in addition to an organic extract of L. leonurus were tested in vivo, ex vivo and in vitro for their anticoagulant, antiplatelet and anti-inflammatory activities. RESULTS: Marrubiin and the organic extract suppressed coagulation, platelet aggregation and inflammatory markers. For the coagulation markers it was found that the organic extract and marrubiin significantly prolonged activated partial thromboplastin time (APTT). Fibrin and D-dimer formation were drastically decreased. These findings were observed in an ex vivo model and an obese rat model. Chemokines enhance leukocyte recruitment to inflammatory sites. TNF-α and RANTES secretion were significantly reduced by the extract and marrubiin when determined in the obese rat model relative to the controls. Calcium mobilization and TXB(2) synthesis were suppressed by the extract and marrubiin. An in vitro model was used to elucidate the antiplatelet mechanism and it was found that the extract and marrubiin inhibited platelet aggregation by inhibiting the binding of fibrinogen to glycoprotein (GP) IIb/IIIa receptor in a concentration dependent manner. CONCLUSION: The findings reflect that marrubiin largely contributes to the extract's anticoagulant, antiplatelet and anti-inflammatory effects observed.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Anticoagulants/pharmacology , Diterpenes/pharmacology , Lamiaceae/chemistry , Plant Extracts/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Animals , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/therapeutic use , Anticoagulants/isolation & purification , Anticoagulants/therapeutic use , Blood Coagulation/drug effects , Calcium/metabolism , Chemokine CCL5/metabolism , Diterpenes/isolation & purification , Diterpenes/therapeutic use , Dose-Response Relationship, Drug , Fibrin/biosynthesis , Fibrin Fibrinogen Degradation Products/biosynthesis , Fibrinogen/metabolism , Fibrinolytic Agents/isolation & purification , Fibrinolytic Agents/pharmacology , Fibrinolytic Agents/therapeutic use , Glycoproteins/metabolism , Inflammation/drug therapy , Inflammation/etiology , Inflammation/metabolism , Male , Obesity/complications , Obesity/drug therapy , Obesity/metabolism , Partial Thromboplastin Time , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/isolation & purification , Platelet Aggregation Inhibitors/therapeutic use , Rats , Rats, Wistar , Thromboxanes/biosynthesis , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...